Washburn Theodore James Jr. - Net Worth and Insider Trading

Washburn Theodore James Jr. Net Worth

The estimated net worth of Washburn Theodore James Jr. is at least $58,002 dollars as of 2023-03-27. Washburn Theodore James Jr. is the Principal Accounting Officer of Agios Pharmaceuticals Inc and owns about 2,668 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $58,002. Details can be seen in Washburn Theodore James Jr.'s Latest Holdings Summary section.

Transaction Summary of Washburn Theodore James Jr.

To

Washburn Theodore James Jr. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Washburn Theodore James Jr. owns 1 companies in total, including Agios Pharmaceuticals Inc (AGIO) .

Click here to see the complete history of Washburn Theodore James Jr.’s form 4 insider trades.

Insider Ownership Summary of Washburn Theodore James Jr.

Ticker Comapny Transaction Date Type of Owner
AGIO Agios Pharmaceuticals Inc 2021-08-01 Principal Accounting Officer

Washburn Theodore James Jr. Latest Holdings Summary

Washburn Theodore James Jr. currently owns a total of 1 stock. Washburn Theodore James Jr. owns 2,668 shares of Agios Pharmaceuticals Inc (AGIO) as of February 16, 2023, with a value of $58,002.

Latest Holdings of Washburn Theodore James Jr.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGIO Agios Pharmaceuticals Inc 2023-02-16 2,668 21.74 58,002

Holding Weightings of Washburn Theodore James Jr.


Washburn Theodore James Jr. Form 4 Trading Tracker

According to the SEC Form 4 filings, Washburn Theodore James Jr. has made a total of 5 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 233 shares on February 16, 2023, which brought Washburn Theodore James Jr. around $6,340.

Insider Trading History of Washburn Theodore James Jr.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Washburn Theodore James Jr. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Washburn Theodore James Jr. Ownership Network

Ownership Network List of Washburn Theodore James Jr.

No Data

Ownership Network Relation of Washburn Theodore James Jr.


Washburn Theodore James Jr. Owned Company Details

What does Agios Pharmaceuticals Inc do?

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Who are the key executives at Agios Pharmaceuticals Inc?

Washburn Theodore James Jr. is the Principal Accounting Officer of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Commercial Officer Tsveta Milanova , Chief Financial Officer Cecilia Jones , and director & Chief Executive Officer Brian Goff .

Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary

Over the past 18 months, Washburn Theodore James Jr. made 5 insider transaction in Agios Pharmaceuticals Inc (AGIO) with a net sale of 1,582. Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 100,000 shares made by David P Schenkein ,

In summary, during the past 3 months, insiders sold 100,737 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 100,737 shares. During the past 18 months, 101,582 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 101,582 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NAS:AGIO Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Washburn Theodore James Jr. Mailing Address

Above is the net worth, insider trading, and ownership report for Washburn Theodore James Jr.. You might contact Washburn Theodore James Jr. via mailing address: C/o Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge Ma 02139.